T1	pharmacokinetics 1012 1018	C(max)
T2	drug 1021 1031	Clodronate
T3	mealTime 1080 1139	morning on an empty stomach 2, 1, or 0.5 h before breakfast
T4	pharmacokinetics 112 127	bioavailability
T5	pharmacokinetics 1162 1172	absorption
T6	mealTime 1220 1240	2 h before breakfast
T7	pharmacokinetics 1305 1319;1345 1351	area under the curves
T8	drugClass 131 146	bisphosphonates
T9	mealTime 1357 1387	dose-breakfast interval of 1 h
T10	interaction 1397 1404	reduced
T11	pharmacokinetics 1405 1415	absorption
T12	pharmacokinetics 1461 1471	absorption
T13	value 1472 1475	91%
T14	drug 1526 1536	clodronate
T15	pharmacokinetics 1537 1549	was absorbed
T16	value 1555 1567	69% efficacy
T17	mealTime 1584 1619	breakfast followed only 0.5 h later
T18	mealTime 1625 1664	dose-breakfast intervals of 0.5 and 1 h
T19	food 170 174	food
T20	pharmacokinetics 1722 1732	Absorption
T21	value 1747 1755	only 34%
T22	mealTime 1808 1827	2 h after breakfast
T23	value 1833 1841	only 10%
T24	pharmacokinetics 184 211	gastrointestinal absorption
T25	drug 1858 1868	clodronate
T26	mealTime 1879 1893	with breakfast
T27	drug 1953 1960	Bonefos
T28	mealTime 1977 2037	morning on an empty stomach at least 0.5 h before breakfast.
T29	pharmacokinetics 352 367	bioavailability
T30	drug 371 381	clodronate
T31	mealTime 413 444	2, 1, or 0.5 h before breakfast
T32	mealTime 446 460	with breakfast
T33	mealTime 465 484	2 h after breakfast
T34	pharmacokinetics 49 64	bioavailability
T35	studyType 545 619	single-center, open, balanced, randomized, crossover pharmacokinetic study
T36	population 623 662	31 healthy subjects aged 21 to 34 years
T37	drug 68 78	clodronate
T38	dosage 724 730	800 mg
T39	mode 734 738	oral
T40	drug 739 749	clodronate
T41	pharmacokinetics 877 891;917 922	area under the curve
T42	pharmacokinetics 932 935	AUC
T43	drug 947 957	clodronate
T44	value 95 111	low and variable
T45	pharmacokinetics 966 987	maximal concentration
T46	drug 991 1001	clodronate
A1	valence T10 Diminution
R1	absorption_decrease Arg1:T19 Arg2:T8	
